Double maintains 1 strategies that include AMRX - Amneal Pharmaceuticals, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DAO | 0.14% | $276.47M | +139.85% | 0.00% |
CREG | -0.30% | $16.80M | -32.73% | 0.00% |
CPSH | -0.43% | $27.45M | +8.62% | 0.00% |
CNK | -0.44% | $3.67B | +78.94% | 0.25% |
EVGO | 0.57% | $532.65M | +68.22% | 0.00% |
CME | 0.86% | $98.74B | +28.80% | 3.84% |
QNTM | 1.01% | $21.04M | -55.31% | 0.00% |
UNH | 1.01% | $248.87B | -47.37% | 3.06% |
COR | 1.03% | $55.43B | +28.90% | 0.56% |
RLX | -1.06% | $1.77B | -9.30% | 0.49% |
FROG | -1.07% | $4.95B | +31.26% | 0.00% |
VHC | 1.08% | $34.69M | +74.89% | 0.00% |
BZUN | 1.13% | $176.55M | +6.15% | 0.00% |
KR | -1.13% | $44.68B | +24.17% | 1.89% |
TXMD | 1.15% | $16.90M | -31.13% | 0.00% |
QNRX | -1.18% | $4.53M | -71.65% | 0.00% |
ALHC | 1.27% | $2.95B | +113.16% | 0.00% |
LTM | -1.31% | $11.01B | -96.75% | 2.75% |
ED | 1.37% | $36.75B | +5.26% | 3.28% |
VZ | 1.42% | $183.32B | +8.02% | 6.21% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ICUI | 52.01% | $3.46B | +32.25% | 0.00% |
CSGS | 51.20% | $1.89B | +51.23% | 1.87% |
XPEL | 50.72% | $1.03B | +10.69% | 0.00% |
DGII | 50.49% | $1.23B | +23.61% | 0.00% |
PH | 49.83% | $85.95B | +24.68% | 0.99% |
SPB | 49.12% | $1.61B | -30.85% | 2.73% |
JXN | 49.09% | $6.09B | +12.55% | 3.41% |
HLNE | 48.46% | $7.37B | +44.47% | 1.15% |
BN | 48.42% | $98.39B | +33.78% | 0.55% |
CPRX | 48.34% | $2.90B | +45.00% | 0.00% |
YETI | 48.23% | $2.66B | -20.79% | 0.00% |
JHG | 47.53% | $6.05B | +12.18% | 4.08% |
CRH | 47.39% | $66.31B | +18.04% | 0.00% |
BNT | 47.33% | $11.98B | +33.22% | 0.00% |
HROW | 47.23% | $940.24M | +58.54% | 0.00% |
ACVA | 47.08% | $2.90B | -7.13% | 0.00% |
CIGI | 47.06% | $6.48B | +9.79% | 0.23% |
MFA | 46.94% | $1.01B | -10.64% | 14.30% |
CPAY | 46.58% | $24.48B | +22.75% | 0.00% |
NCZ | 46.58% | - | - | 5.92% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -11.12% | $21.28M | -72.45% | 0.00% |
STG | -10.67% | $27.05M | -37.35% | 0.00% |
RLMD | -8.94% | $13.72M | -88.15% | 0.00% |
VSA | -8.61% | $7.04M | -49.24% | 0.00% |
K | -8.49% | $28.49B | +32.17% | 2.77% |
FMTO | -6.72% | $45.74M | -99.96% | 0.00% |
AQB | -5.53% | $2.96M | -61.58% | 0.00% |
DG | -4.61% | $20.45B | -36.56% | 2.55% |
GFI | -4.41% | $18.61B | +31.67% | 2.75% |
AGL | -4.13% | $1.06B | -54.30% | 0.00% |
MCK | -3.66% | $88.42B | +27.17% | 0.39% |
ASPS | -3.25% | $69.98M | -57.72% | 0.00% |
PULM | -3.25% | $23.82M | +239.64% | 0.00% |
CBOE | -2.96% | $22.95B | +20.67% | 1.12% |
IRWD | -2.65% | $96.19M | -91.05% | 0.00% |
HUM | -2.38% | $27.45B | -35.96% | 1.55% |
SRRK | -2.19% | $2.92B | +115.29% | 0.00% |
TLPH | -2.12% | $10.05M | -57.39% | 0.00% |
TH | -1.72% | $690.70M | -39.27% | 0.00% |
MNST | -1.60% | $60.79B | +15.23% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -45.18% | $109.64M | 0.85% |
TAIL | -43.54% | $140.49M | 0.59% |
BTAL | -29.09% | $361.41M | 1.43% |
IVOL | -20.13% | $353.94M | 1.02% |
XONE | -19.70% | $603.24M | 0.03% |
FXY | -18.11% | $838.61M | 0.4% |
TFLO | -16.85% | $7.06B | 0.15% |
FTSD | -15.80% | $212.46M | 0.25% |
WEAT | -15.13% | $115.83M | 0.28% |
SPTS | -14.13% | $5.76B | 0.03% |
XHLF | -13.50% | $1.46B | 0.03% |
BILS | -11.70% | $3.96B | 0.1356% |
KCCA | -10.71% | $97.18M | 0.87% |
SCHO | -10.58% | $10.87B | 0.03% |
CORN | -10.24% | $49.57M | 0.2% |
BIL | -10.15% | $45.95B | 0.1356% |
GBIL | -9.53% | $6.17B | 0.12% |
VGSH | -8.90% | $22.38B | 0.03% |
SHV | -8.78% | $20.94B | 0.15% |
UTWO | -8.37% | $387.71M | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XPH | 59.32% | $136.58M | 0.35% |
PSC | 55.76% | $811.78M | 0.38% |
XHE | 55.69% | $171.93M | 0.35% |
DUHP | 55.48% | $8.05B | 0.21% |
IWM | 55.20% | $63.95B | 0.19% |
VTWO | 55.11% | $12.07B | 0.07% |
GSSC | 55.04% | $538.65M | 0.2% |
PRFZ | 54.92% | $2.33B | 0.34% |
SMMD | 54.88% | $1.46B | 0.15% |
FNDA | 54.70% | $8.30B | 0.25% |
DTD | 54.66% | $1.33B | 0.28% |
SCHA | 54.52% | $16.91B | 0.04% |
DFAC | 54.49% | $32.90B | 0.17% |
IJR | 54.40% | $79.01B | 0.06% |
ISCG | 54.38% | $645.00M | 0.06% |
QUS | 54.37% | $1.49B | 0.15% |
VIOV | 54.33% | $1.27B | 0.1% |
RSPA | 54.24% | $319.03M | 0.29% |
VIOO | 54.23% | $2.88B | 0.1% |
DGRW | 54.11% | $15.01B | 0.28% |
Yahoo
Brekiya® becomes the first and only DHE autoinjector that allows patients to self-administer the same medication used in hospitals in a ready-to-use form Product will be available for appropriate patients in the second half of 2025 BRIDGEWATER, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya® (dihydroergotamine mesylate) injection, the first and onl
Finnhub
Amneal Pharmaceuticals said on Thursday the U.S. Food and Drug Administration has approved its self-administered migraine drug, sending its shares up 6% in premarket trading. The drug,...
Finnhub
Amneal Pharmaceuticals saidon Thursday the U.S. Food and Drug Administration has approvedits self-administered migraine drug. ...
Finnhub
Amneal Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved Brekiya®? injection, the first and only dihydroergotamine autoinjector for the acute treatment of...
Finnhub
BRIDGEWATER - Amneal Pharmaceuticals, Inc. , an American biopharmaceutical company, and Apiject Systems, Corp. , a medical technology company focused on advanced drug delivery, announced a strategic...
Yahoo
-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation -Expands Amneal’s extensive domestic pharmaceutical manufacturing footprint BRIDGEWATER, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), an American biopharmaceutical company, and Apiject Systems, Corp. (“Apiject”), a medical technology company focused on advanced drug delivery, to
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPTI | 0.51% | $8.70B | 0.03% |
IBTK | -0.58% | $431.59M | 0.07% |
JMST | -0.58% | $3.65B | 0.18% |
KRBN | -0.73% | $160.09M | 0.85% |
BOXX | -0.75% | $6.21B | 0.19% |
CGSM | 0.75% | $658.61M | 0.25% |
IBTL | 0.79% | $367.56M | 0.07% |
BSV | 0.81% | $38.35B | 0.03% |
VGIT | 0.91% | $31.33B | 0.04% |
JPST | 0.93% | $30.82B | 0.18% |
STPZ | 0.96% | $446.46M | 0.2% |
SHY | -0.98% | $24.03B | 0.15% |
ICSH | 1.02% | $6.10B | 0.08% |
IEI | -1.04% | $16.09B | 0.15% |
CARY | 1.09% | $347.36M | 0.8% |
SMB | -1.15% | $269.10M | 0.07% |
IBND | -1.25% | $291.26M | 0.5% |
TBIL | -1.38% | $5.76B | 0.15% |
BSMW | -1.60% | $102.62M | 0.18% |
IGOV | -1.71% | $994.85M | 0.35% |
Current Value
$7.491 Year Return
Current Value
$7.491 Year Return